Amylyx Pharmaceuticals, Inc. <AMLX.O>: Mizuho raises target price to $42 from $30
AMLX•Related News
Target Q2 Adjusted EPS USD 4.11
TGT•
Caleres schedules Q2 2026 earnings release and conference call
CAL•
Ionis Pharmaceuticals, Inc. <IONS.O>: BMO initiates coverage with market perform rating; price target $60
IONS•
Target lifts annual forecasts again as Fiddelke's turnaround takes root
TGT•
Estee Lauder forecasts strong annual profit on resilient fragrance demand
EL•